Med. IQR Med. IQR Size 95% *% of CI NI > median NG Gastric -2 370 0-837 560 200-760 0.04 0.25, 60% 0.31 Loss -1 850 885 590-1090 0.07 0.21, 52% (mL) 0.36 1 250 0-460 690 400-1055 0.43 0.15, 84% 0.66 2 0 0-58 480 162-975 0.58 0.37, 92% 0.76 3 0 0-0 455 246-898 0.71 0.51, 92% 0.87 4 0 0-205 295 19-739 0.29 0.00, 76% 0.55 5 0 0-181 69 0-482 0.27 0.04, 60% 0.55 EN -2 1104 1190 734-1618 0.10 -495, 60% 231 delivered -335, 40% (mL) -1 1117 964 785-1494 0.04 420 1 1124 1497 1405-1593 0.37 -673, 92% -67 2 1650 1808 1384-1947 0.11 -493, 64% 179 3 1726 1880 1658-2172 0.23 -691, 68% 72 4 1492 1945 1634-2382 0.37 -1022, 92% -112 -921, 76% 5 1585 1917 1491-2392 0.31 -52 Kcal -2 1300 1184 758-1478 0.01 -321, 56% 377 Delivered -1 1338 1002 657-1237 0.23 -69, 24% 654 1 1249 1510 1428-1611 0.18 -565, 84% -11 2 1718 1791 1396-2159 0.07 -424, 56% 89 3 1883 1750 1523-2030 0.11 -391, 44% 374 4 1579 1805 1589-2115 -770, 76% 310 5 1729 1684 1535-2128 -602, 52% 290
Med. IQR Med. IQR Size 95% CI *% of NI > median NG Gastric Loss (mL) -2 370 0-837 560 200-760 0.04 0.25, 0.31 60% -1 850 885 590-1090 0.07 0.21, 0.36 52% 1 250 0-460 690 400-1055 0.43 0.15, 0.66 84% 2 0 0-58 480 162-975 0.58 0.37, 0.76 92% 3 0 0-0 455 246-898 0.71 0.51, 0.87 92% 4 0 0-205 295 19-739 0.29 0.00, 0.55 76% 5 0 0-181 69 0-482 0.27 0.04, 0.55 60% EN delivered (mL) -2 1104 1190 734-1618 0.10 -495, 231 60% -1 1117 964 785-1494 0.04 -335, 420 40% 1 1124 1497 1405-1593 0.37 -673, -67 92% 2 1650 1808 1384-1947 0.11 -493, 179 64% 3 1726 1880 1658-2172 0.23 -691, 72 68% 4 1492 1945 1634-2382 0.37 -1022, -112 92% 5 1585 1917 1491-2392 0.31 -921, -52 76% Kcal Delivered -2 1300 1184 758-1478 0.01 -321, 377 56% -1 1338 1002 657-1237 0.23 -69, 654 24% 1 1249 1510 1428-1611 0.18 -565, -11 84% 2 1718 1791 1396-2159 0.07 -424, 89 56% 3 1883 1750 1523-2030 0.11 -391, 374 44% 4 1579 1805 1589-2115 -770, 310 76% 5 1729 1684 1535-2128 -602, 290 52%
feasibility%20and%20proofConcept%20RCT-STaylor2016.docx